Saturday, February 4, 2023

Roche’s Failed Alzheimer’s Drug Cleared Less Amyloid Than Hoped, Results Show

Must Read

Roche Holding AG’s experimental Alzheimer’s disease drug gantenerumab was far less effective than hoped at clearing a toxic protein from the brain, according to findings from two studies that may explain why it failed when a therapy from rival Eisai Co. succe…
Read More

- Advertisement -spot_imgspot_imgspot_img
- Advertisement -spot_img
Latest News


February is pretty, don’t you think? It’s like living in a snow-globe. I suppose I could complain about the...
- Advertisement -spot_img

More Articles Like This

- Advertisement -spot_imgspot_imgspot_imgspot_img
Verified by MonsterInsights